Speaker illustration

Doctor Masato Okada

Sakurabashi-Watanabe Hospital, Osaka (Japan)

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr. Masato Okada is a cardiologist at Sakurabashi Watanabe Hospital, Osaka, Japan. He graduated from Osaka University in 2008, and was trained in general cardiology and electrophysiology at Osaka Police Hospital. From 2015, he has worked at Sakurabashi Watanabe Hospital as a cardiologist and specializes in arrhythmias. His field of interest is the role of arrhythmias in the progression of heart failure.

Impact of heart rate reduction on recurrence after catheter ablation of persistent atrial fibrillation

Event: ESC Asia with APSC & AFC 2021

Topic: Rhythm Control, Catheter Ablation

Session: ePosters

Thumbnail

Reappraising the role of baseline plasma C-reactive protein levels on recurrence after catheter ablation of persistent atrial fibrillation: insight from EARNEST-PVI trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation e-posters

Thumbnail

Association between myocardial wall thickness and left ventricular functional recovery after catheter ablation of atrial fibrillation in patients with reduced ejection fraction

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation e-posters

Thumbnail

The impact of frailty and aging on prognosis in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry -

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure ePosters

Thumbnail

The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pathophysiology

Session: Chronic Heart Failure ePosters

Thumbnail

Post-procedural plasma brain natriuretic peptide level early after catheter ablation predicts the future clinical outcome in patients with persistent atrial fibrillation and reduced ejection fraction

Event: ESC CONGRESS 2019

Topic: Rhythm Control, Catheter Ablation

Session: Ablation of persistent atrial fibrillation

Thumbnail

Prevalence, predictors, and clinical outcome of left ventricular reverse remodeling after catheter ablation for atrial fibrillation in patients with reduced ejection fraction

Event: ESC Congress 2018

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation - ablation

Thumbnail

This platform is supported by

logo Novo Nordisk